About Oregon Therapeutics

About company

The resistance mechanisms or resistance-associated changes have been reported for > 80% of currently approved drugs. The need to combat drug resistance is a key driver of anticancer drug discovery. It is a major issue in the daily oncology practice with dramatic consequences for the cancer patients. It is actually a common reason why advanced cancers are so often fatal.